K223553 is an FDA 510(k) clearance for the Spine Planning (2.0), Elements Spine Planning, Elements Planning Spine. Classified as Orthopedic Stereotaxic Instrument within the OLO classification (a category covering orthopedic stereotaxic and surgical navigation instruments), Class II - Special Controls.
Submitted by Brainlab AG (Munich, DE). The FDA issued a Cleared decision on August 2, 2023 after a review of 250 days - an extended review cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 882.4560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Brainlab AG devices